Literature DB >> 5822582

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.

M B Bernik, H C Kwaan.   

Abstract

Human tissues and cells from pre- and postnatal life were cultivated and studied for plasminogen activator activity. Cultures were obtained from kidney, renal blood vessels, ureter, bladder, lung, and heart. Local activator activity of cells was demonstrated by histochemical techniques. Activator released by cells into the supernatant culture media was assayed by fibrin plate techniques and was investigated for immunological identity using specific antisera to an activator of human origin, urokinase (UK). Plasminogen activator was produced in primary cultures where cells retain specific functions and generally reflect the enzyme pattern of the tissues of origin. Cells from fetal and adult sources were found to yield activator antigenically identical to UK, as well as activator activity which differed from that of UK in immunoassays and which may represent tissue type activator. Such activity was released after injury or death of cells while UK was produced in cultures containing live, metabolizing cells. Primary cultures of kidney confirmed that this organ is a rich source of UK and demonstrated, in addition, that UK is produced from the early stages of gestation and in increasing amounts thereafter. However, primary cultures also demonstrated that the ability to produce UK is not limited to the kidney but is a function of cells which are distributed widely in body tissues. Thus, activator antigenically identical to UK accumulated progressively after many refeedings in culture supernates of fetal lung and ureter, as well as in supernates of renal blood vessels of adults. These findings indicate continuous formation of UK by the cultured cells and, furthermore, provide evidence of UK production in blood vessels. In cultures from other tissues, particularly those from fetal heart and adult lung and bladder, investigation of activator was hindered by inhibitory activity which accumulated in the supernates. Such activity was derived from cells in culture and was directed selectively against UK, indicating that inhibitor as well as UK are produced by cells of various organs of the body. Plasminogen activator also was produced by serially propagated cells, diploid and heteroploid. However, only diploid cell lines retained activator activity of the original tissues and continued to produce activator antigenically identical to UK. In contrast, heteroploid line appeared to have lost the ability to form UK by yielded activator activity that differed from that of UK in immunoassays. Serially propagated cells thus provide an additional tool for in vitro study of plasminogen activator and may facilitate investigation of the fibrinolytic system in man.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822582      PMCID: PMC535746          DOI: 10.1172/JCI106140

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The preparation of human fibrinolysin (plasmin).

Authors:  J T SGOURIS; J K INMAN; K B McCALL; L A HYNDMAN; H D ANDERSON
Journal:  Vox Sang       Date:  1960-07       Impact factor: 2.144

2.  Activation of plasminogen.

Authors:  S MULLERTZ
Journal:  Ann N Y Acad Sci       Date:  1957-08-30       Impact factor: 5.691

3.  On the production of plasma fibrinolytic activity within veins.

Authors:  H C KWAAN; R LO; A J MCFADZEAN
Journal:  Clin Sci       Date:  1957-05       Impact factor: 6.124

4.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

5.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

6.  Characterization of a soluble plasminogen activator from kidney cell cultures.

Authors:  R H PAINTER; A F CHARLES
Journal:  Am J Physiol       Date:  1962-06

7.  Release of plasminogen activator by the isolated perfused dog kidney.

Authors:  R Holemans; J G Johnston; R L Reddick
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

8.  The isolation and characterization of plasminogen activators (urokinase) from human urine.

Authors:  W F White; G H Barlow; M M Mozen
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

9.  Urokinase inhibitor in human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  Nature       Date:  1968-01-20       Impact factor: 49.962

10.  Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.

Authors:  P Kok; T Astrup
Journal:  Biochemistry       Date:  1969-01       Impact factor: 3.162

View more
  32 in total

1.  Fibrinolytic activity of in vitro cultivated human bladder cell lines.

Authors:  H Hisazumi; L Andersson; V P Collins
Journal:  Urol Res       Date:  1977

2.  Antifibrinolytic properties of oxyphenbutazone in vitro.

Authors:  M Pandolfi; K Dyster-Aas; B Astedt
Journal:  Experientia       Date:  1976-02-15

3.  In vitro release of fibrinolytic activators from cornea.

Authors:  E Lantz; K Dyster-Aas; M Pandolfi
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-05-16

4.  Continuous flow electrophoretic separation of proteins and cells from mammalian tissues.

Authors:  W C Hymer; G H Barlow; S J Blaisdell; C Cleveland; M A Farrington; M Feldmeier; R Grindeland; J M Hatfield; J W Lanham; M L Lewis
Journal:  Cell Biophys       Date:  1987-02

5.  Purification of plasminogen activators from human seminal plasma.

Authors:  D Propping; L J Zaneveld; P F Tauber; G F Schumacher
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

6.  Protease effects on specific growth properties of normal and transformed baby hamster kidney cells.

Authors:  M Brown; D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

7.  Release of plasminogen activator from normal and neoplastic endometrium.

Authors:  L Svanberg; B Astedt
Journal:  Experientia       Date:  1979-06-15

8.  Urokinase inhibitor in patients with bladder cancer.

Authors:  H Hisazumi; K Naito; T Misaki; S Kosaka
Journal:  Urol Res       Date:  1974-12-20

9.  Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

Authors:  M A Olman; N Mackman; C L Gladson; K M Moser; D J Loskutoff
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  Modulation of cell-associated plasminogen activator activity by cocultivation of a stem cell and its tumorigenic descendant.

Authors:  H Y Liu; P P Yang; D L Toledo; W F Mangel
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.